반응식
[CH:1]([NH:4][C:5]([C@H:7]1[CH2:12][CH2:11][C@@H:10]([NH:13][C:14]2[C:19]([N+:20]([O-])=O)=[CH:18][N:17]=[C:16]([O:23][CH2:24][CH2:25][O:26][CH3:27])[CH:15]=2)[CH2:9][CH2:8]1)=[O:6])([CH3:3])[CH3:2].NC1C(N[C@@H]2CC[C@H](C(NC(C)C)=O)CC2)=CC(Cl)=NC=1>>[NH2:20][C:19]1[C:14]([NH:13][C@@H:10]2[CH2:11][CH2:12][C@H:7]([C:5]([NH:4][CH:1]([CH3:3])[CH3:2])=[O:6])[CH2:8][CH2:9]2)=[CH:15][C:16]([O:23][CH2:24][CH2:25][O:26][CH3:27])=[N:17][CH:18]=1참가 물질
3
실험 절차
The title compound was prepared from cis-N-isopropyl-4-(2-(2-methoxyethoxy)-5-nitropyridin-4-ylamino)cyclohexanecarboxamide using a procedure analogous to that used in the preparation of cis-4-(5-amino-2-chloropyridin-4-ylamino)-N-isopropylcyclohexanecarboxamide.
출처 및 근거
- ORD 기록
- ord-7a52682c005e40c892a0b9fce62f4186
- 출처 데이터셋
- uspto-grants-2015_08
- 특허 번호
- US09115127B2
연결된 노트
불러오는 중…